首页> 外文期刊>Open Chemistry >Preparation and Application of a Nano α-Fe2O3/SAPO-34 Photocatalyst for Removal of the Anti-cancer Drug Doxorubicin using the Taguchi Approach
【24h】

Preparation and Application of a Nano α-Fe2O3/SAPO-34 Photocatalyst for Removal of the Anti-cancer Drug Doxorubicin using the Taguchi Approach

机译:Taguchi法制备纳米α-Fe 2 O 3 / SAPO-34光催化剂用于抗癌药物阿霉素的制备及应用

获取原文
       

摘要

The synthesis of α-Fe2O3/SAPO-34 nano photocatalyst was the first step of this study. The α-Fe2O3 nanocatalyst was synthesized applying forced hydrolysis and reflux condensation followed by solid-state dispersion that was used for supporting α-Fe2O3 on SAPO-34. The next step was a characterization of the catalyst that was performed using X-ray diffraction (XRD), scanning electron microscopy (SEM) and Fourier Transform Infrared Spectroscopy (FT-IR). Then, for optimizing the operational parameters in Doxorubicin’s degradation process the effect of Doxorubicin concentration, the amount of α-Fe2O3/SAPO-34 nano photocatalyst, the pH, and H2O2 concentration was studied via the Taguchi method. The AL9 orthogonal array was adjusted and nine crucial runs were conducted. For calculating Signal/Noise ratio, each run was repeated three times. As the results showed, the concentration of Doxorubicin is the most effective parameter. Optimized conditions for removing the anti-cancer drug (based on Signal/Noise ratio) were Doxorubicin concentration (20 ppm), H2O2 concentration (3 mol/L), catalyst amount (50 mg/L) and pH = 8.
机译:这项研究的第一步是合成α-Fe2O3/ SAPO-34纳米光催化剂。通过强制水解和回流缩合,然后使用固态分散体(用于将α-Fe2O3负载在SAPO-34上),合成了α-Fe2O3纳米催化剂。下一步是使用X射线衍射(XRD),扫描电子显微镜(SEM)和傅立叶变换红外光谱(FT-IR)对催化剂进行表征。然后,为了优化阿霉素降解过程中的操作参数,通过Taguchi方法研究了阿霉素浓度,α-Fe2O3/ SAPO-34纳米光催化剂的量,pH和H2O2浓度的影响。调整了AL9正交阵列,并进行了9次关键运行。为了计算信噪比,每次运行重复三次。结果表明,阿霉素的浓度是最有效的参数。去除抗癌药物的最佳条件(基于信噪比)是阿霉素浓度(20 ppm),过氧化氢浓度(3 mol / L),催化剂用量(50 mg / L)和pH = 8。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号